Out of control: Accelerated aging in uremia

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 48-54

  Kooman, Jeroen P ^a   Broers, Natascha J H ^a   Usvyat, Len ^b   Thijssen, Stephan ^b   Van Der Sande, Frank M ^a   Cornelis, Tom ^a   Levin, Nathan W ^b   Leunissen, Karel M L ^a   Kotanko, Peter ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

accelerated aging; inflammation; malnutrition; sarcopenia; uremia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KLOTHO PROTEIN;

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FRAIL ELDERLY; FUNCTIONAL STATUS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFECTION RISK; INFLAMMATION; KIDNEY FAILURE; LUNG INFECTION; MORTALITY; MUSCLE ATROPHY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TELOMERE; UREMIA;

AGING; AGING, PREMATURE; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS; UREMIA;

EID: 84872253284     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs451     Document Type: Article

References (67)

1. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis 2009; 53: S4-S16
2. Jadoulle V, Hoyois P, Jadoul M. Anxiety and depression in chronic hemodialysis: some somatopsychic determinants. Clin Nephrol 2005; 63: 113-118
3. McIntyre CW, Rosansky SJ. Starting dialysis is dangerous: how do we balance the risk? Kidney Int 2012 [Epub ahead of print April 25]
4. Rao M. Aging and nephrology-The Sun sets. Indian J Nephrol 2005; 15(Suppl 2): S3-S6
5. Kuro OM. Phosphate and Klotho. Kidney Int 2011; 79(Suppl 121): S20-S23
6. Girndt M. Seibert Premature cardiovascular disease in chronic renal failure (CRF): a model for an advanced ageing process. Exp Gerontol 2010; 45: 797-800
7. Amann K, Ritz E. Cardiovascular abnormalities in ageing and in uraemia-only analogy or shared pathomechanisms? Nephrol Dial Transplant 1998; 13(Suppl 7): 6-11
8. Kooman JP, Usvyat L, van der Sande FM et al. 'Time and time again': oscillatory and longitudinal time patterns in dialysis patients. Kidney Blood Press Res 2012; 35: 534-548
9. Koopman JJ, Rozing MP, Kramer A et al. Senescence rates in patients with end-stage renal disease: a critical appraisal of the Gompertz model. Aging Cell 2011; 10: 233-238
10. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; (Suppl 3): S112-S119
11. Vanholder R, Van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20: 477-480
12. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-1533
13. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120: 1883-1887
14. Painter P, Carlson L, Carey S et al. Physical functioning and healthrelated quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis 2000; 35: 482-492
15. van den Ham EC, Kooman JP, Schols AM et al. Similarities in skeletal muscle strength and exercise capacity between renal transplant and hemodialysis patients. Am J Transplant 2005; 5: 1957-1965
16. Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 2010; 91(Suppl): 1123S-1127S
17. Kooman JP, Cornelis T, van der Sande FM et al. Renal replacement therapy in geriatric end-stage renal disease patients: a clinical approach. Blood Purif 2012; 33: 171-176
18. Johansen KL, Chertow GM, Jin C et al. Significance of frailty among dialysis patients. J Am Soc Nephrol 2007; 18: 2960-2967
19. Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int 2011; 79: 14-22
20. Weinert BT, Timiras PS. Theories of aging. J Appl Physiol 2003; 95: 1706-1716
21. Carracedo J, Merino A, Briceño C et al. Carbamylated lowdensity lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J 2011; 25: 1314-1322
22. Jimenez R, Carracedo J, Santamaría R et al. Replicative senescence in patients with chronic kidney failure. Kidney Int 2005; 99(Suppl): S11-S15
23. Carrero JJ, Stenvinkel P, Fellström B et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302-312
24. Vogelmeier C, Bals R. Chronic obstructive pulmonary disease and premature aging. Am J Respir Crit Care Med 2007; 175: 1217-1218
25. Guaraldi G, Orlando G, Zona S et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53: 1120-1126
26. Ershler WB. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol 2007; 103: 3-5
27. Stenvinkel P, Heimburger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-960
28. Westendorp RG. What is healthy aging in the 21st century. Am J Clin Nutr 2006; 83(Suppl): 404S-409S
29. Fulop T, Larbi A, Witkowski JM et al. Aging, frailty, and agerelated diseases. Biogerontology 2010; 11: 547-563
30. Hubbard RE, Woodhouse KW. Frailty, inflammation and the elderly. Biogerontology 2010; 11: 635-641
31. Hasselgren PO. Ubiquitination, phosphorylation, and acetylation-triple threat in muscle wasting. J Cell Physiol 2007; 213: 679-689
32. Feng B, Zhang YQ, Mu J et al. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway. Exp Physiol 2011; 96: 801-815
33. Himmelfarb J, Stenvinkel P, Ikizler TA et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538
34. Agrawal A, Sridharan A, Prakash S et al. Dendritic cells and aging: consequences for autoimmunity. Expert Rev Clin Immunol 2012; 8: 73-80
35. Lim WH, Kireta S, Russ GR et al. Uremia impairs blood dendritic cell function in hemodialysis patients. Kidney Int 2007; 71: 1122-1131
36. Lee JS, Lee WW, Kim SH et al. Age-associated alteration in naive and memory Th17 cell response in humans. Clin Immunol 2011; 140: 84-91
37. Stout-Delgado HW, Du W, Shirali AC et al. Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection. Cell Host Microbe 2009; 6: 446-456
38. Chung BH, Kim KW, Sun IO et al. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett 2012; 141: 181-189
39. Perez-Lopez FR, Chedraui P, Fernandez-Alonso AM. Vitamin D and aging: beyond calcium and bone metabolism. Maturitas 2011; 69: 27-36
40. Adelibieke Y, Shimizu H, Muteliefu G et al. Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. J Ren Nutr 2012; 22: 86-89
41. Jourde-Chiche N, Dou L, Cerini C et al. Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 2011; 24: 327-337
42. McIntyre CW, Harrison LE, Eldehni MT et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 133-141
43. Carracedo J, Ramírez R, Madueño JA et al. Cell apoptosis and hemodialysis-induced inflammation. Kidney Int Suppl 2002; 80: 89-93
44. Cooper BA, Branley P, Bulfone L et al.; IDEAL Study. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619
45. Liem YS, Weimar W. Early living-donor kidney transplantation: a review of the associated survival benefit. Transplantation 2009; 87: 317-318
46. Charansonney OL. Physical activity and aging: a life-long story. Discov Med 2011; 12: 177-185
47. Phan HM, Alpert JS, Fain M. Frailty, inflammation, and cardiovascular disease: evidence of a connection. Am J Geriatr Cardiol 2008; 17: 101-107
48. Yates FE, Benton LA. Loss of integration and resiliency with age: a dissipative destruction. In: Masoro EJ (ed). Handbook of Physiology: Aging. New York: Oxford University Press and the American Physiological Society, 1995, pp. 591-610
49. Gavrilov LA, Gavrilova N. The reliability theory of aging and longevity. J Theor Biol 2001; 213: 527-545
50. Nicolini P, Ciulla MM, Asmundis CD et al. The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathovagal balance to chaos theory. Pacing Clin Electrophysiol 2012; 35: 622-638
51. Ranpuria R, Hall M, Chan CT et al. Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant 2008; 23: 444-449
52. Lipsitz LA, Goldberger AL. Loss of 'complexity' and aging. JAMA 1992; 2671: 806-809
53. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009; 539-549
54. Ronco C, Kaushik M, Valle R et al. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the '5B' approach. Semin Nephrol 2012; 32: 129-141
55. Jacobs LH, van de Kerkhof JJ, Mingels AM et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant 2010; 25: 243-248
56. Strulik H, Vollmer S. Long-run rends of human aging and longevity. Harvard initiative of global health. PDGA Working paper no 73. http://www.hsph.harvard.edu/pdga/working.htm.
57. Dalrymple LS, Mohammed SM, Mu Y et al. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol 2011; 6: 1708-1713
58. Kurella Tamura M, Covinsky KE, Chertow GM et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009; 361: 1539-1547
59. Krane V, Drechsler C, Wanner C. Dyslipidemia, inflammation and dialysis outcomes: what we know now. Curr Opin Nephrol Hypertens 2006; 15: 566-570
60. Grooteman MP, van den Dorpel MA, Bots ML et al.; for the CONTRAST Investigators. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096
61. Johansen KL, Zhang R, Huang Y et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76: 984-990
62. Yuen DA, Kuliszewski MA, Liao C et al. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol 2011; 6: 1345-1353
63. Jassal SV, Watson D. Doc, don't procrastinate?Rehabilitate, palliate, and advocate. Am J Kidney Dis 2010; 55: 209-212
64. Munoz Mendoza J, Isakova T, Ricardo AC et al.; for the Chronic Renal Insufficiency Cohort. Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 2012. [Epub ahead of print]
65. Muntinghe FL, Verduijn M, Zuurman MW et al. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol 2009; 20: 1641-1649
66. Shimoyama Y, Mitsuda Y, Tsuruta Y et al. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. J Ren Nutr 2012; 22: 114-119
67. Fairhall N, Langron C, Sherrington C et al. Treating frailty-a practical guide. BMC Med 2011; 9: 83.